Nonapeptide-1
Melanostatine-5
COSMETIC CLINICAL STUDIES · COSMETIC PEPTIDE; MC1R ANTAGONIST
▓ 6 indexed citations across PubMed (3), EuropePMC (3).
Citation breakdown by evidence tier
← weaker evidence · stronger evidence →
Tap any tier to jump to that section of the bibliography.
Mechanism of action
Blocks α-MSH binding at MC1R; reduces melanogenesis
Researched effects
Skin brightening; pigment control
Live evidence
Recent literature
- Discovery of a Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening.
- Stellarin I: A Bioactive Cyclic Nonapeptide with Potent Anti-renal Fibrosis Activity from the Root of Stellaria yunnanensis Franch.
- Enhanced skin benefits of EGCG loaded in nonapeptide-1-conjugated mesoporous silica nanoparticles to reverse skin photoaging.
Live signals refreshed daily. Current as of November 19, 2026.
Dosing reported in literature
Topical 0.01-0.05%
Known concerns
Minimal
Top-ranked picks
6 pre-curated authoritative sources, ranked by journal tier and study weight.
- A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance.
- Discovery of a Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening.
- Stellarin I: A Bioactive Cyclic Nonapeptide with Potent Anti-renal Fibrosis Activity from the Root of Stellaria yunnanensis Franch.
- Enhanced skin benefits of EGCG loaded in nonapeptide-1-conjugated mesoporous silica nanoparticles to reverse skin photoaging.
- Effects of tea polyphenols on UVA-induced melanogenesis via inhibition of α-MSH-MC1R signalling pathway.
- Efficacy, Safety and Targets in Topical and Transdermal Active and Excipient Delivery
Full citation library
Year distribution
No references match — clear filters.
Randomised Controlled Trials
1-
1.
Melasma is the commonest cause of facial hypermelanosis in skin type IV-VI. First-line treatment includes a triple combination containing topical corticosteroid and hydroquinone which have side effects on prolonged use. Chemical peels are a second-line management option with the laser being used in refractory cases, but the worsening of hyperpigmentation in darker skin types can occur following laser therapy. Sunscreen is a must to prevent relapses. (i) To compare the effects of treatment with a…
Research Articles
5-
2.
Epigallocatechin-3-gallate (EGCG), a catechin present in green tea, has been studied extensively for its potential as a cosmetic ingredient due to its various biological properties. However, the low stability and bioavailability of EGCG have hindered its effective utilization in cosmetic applications. This study, to improve the stability and bioavailability of EGCG for reversing skin photo-aging, nonapeptide-1-conjugated mesoporous silica nanoparticles (EGCG@NP-MSN) were fabricated to load EGCG.…
-
3.
Ultraviolet (UV) irradiation is a major environmental factor affecting photoaging, which is characterized by skin wrinkle formation and hyperpigmentation. Although many factors are involved in the melanogenesis progress, UV is thought to play a major role in tanning. The pathway of α-melanocyte-stimulating hormone (α-MSH)-melanocortin receptor 1 (MC1R) is associated with UV-induced melanogenesis. Thus, α-MSH antagonists may have applications in the prevention of melanogenesis. To investigate the…
-
4.
<h4>Background</h4>Melanin synthesis plays a crucial role in skin pigmentation, and inhibiting tyrosinase, the key enzyme in melanin production, is a primary strategy for developing skin-lightening agents. This study investigates the tyrosinase inhibitory potential of CHP-9, a novel cyclopeptide, and evaluates its cytotoxicity and efficacy as a cosmetic depigmenting agent.<h4>Methods</h4>CHP-9 was synthesized via a solid-phase peptide synthesis strategy. The tyrosinase inhibitory activity was as…
-
5.
An undescribed cyclic nonapeptide (1) was isolated from the crude root extract of the medicinal plant Stellaria yunnanensis Franch. Comprehensive spectral analysis was performed utilizing high-resolution mass spectrometry, one- and two-dimensional nuclear magnetic resonance spectroscopy, and experimental and calculated circular dichroism spectroscopy to elucidate the structure of the cyclic nonapeptide (1), which was identified as cyclo-(Tyr-Ala-Thr-Leu-Thr-Ala-Phe-Ala-Thr). Anti-renal fibrosis…
- 6.
Curated sources on file
3- 1.
- 2.
-
3.
Note: Primary literature for this commercial cosmetic peptide is limited; cited reviews summarize available preclinical and clinical evidence.